Form 4: Scholar Rock Director Joshua Reed Receives Equity Grant

Sentiment:

Statement of Changes in Beneficial Ownership


Director Joshua Reed acquired 6,839 restricted stock units and 4,310 stock options as part of an annual equity compensation grant.

Summary

  • Director Joshua Reed was granted 6,839 restricted stock units (RSUs) on June 4, 2026.
  • The director also received 4,310 stock options with an exercise price of $45.33.
  • Following these transactions, the director's total beneficial ownership stands at 22,571 shares, including 15,732 common shares and 6,839 RSUs.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which carries a neutral sentiment.

Positives

  • Equity grants align the interests of the director with those of the shareholders.
  • The director maintains a direct ownership stake in the company.

Negatives

  • The issuance of new equity results in minor dilution to existing shareholders.

Risks

  • Vesting of equity is subject to continued service to the issuer.

Future Outlook

The equity grants are subject to vesting conditions tied to the director's continued service through the earlier of the first anniversary of the grant or the next Annual Meeting.

Management Comments

  • The filing does not contain narrative management commentary.

Industry Context

StockSavvy.ai notes that standard director equity compensation packages are common in the biotechnology sector to ensure board member retention and alignment with long-term corporate performance.

Comparison to Industry Standards

  • The grant structure is consistent with standard corporate governance practices for mid-cap biotechnology firms.
  • Vesting schedules tied to annual meetings are typical for non-employee director compensation.

Stakeholder Impact

  • Minor dilution for existing shareholders due to the issuance of new equity.

Next Steps

  • Vesting of RSUs on June 15, 2027, or the date of the next Annual Meeting.
  • Vesting of stock options on the first anniversary of the grant or the date of the next Annual Meeting.

Key Dates

DateDescription
06/04/2026Date of the equity grant transaction.
06/08/2026Date the Form 4 was filed with the SEC.
06/15/2027Vesting date for the restricted stock units.
06/04/2036Expiration date for the stock options.

Keywords

Scholar Rock, SRRK, Form 4, Insider Trading, Equity Compensation, Director Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.